T Cell Subsets in HIV Infected Patients after Successful Combination Antiretroviral Therapy: Impact on Survival after 12 Years

Frederikke F Rönsholt, Sisse Rye Ostrowski, Terese Lea Katzenstein, Henrik Ullum, Jan Gerstoft

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

10 Citationer (Scopus)

Abstract

Immune activation is decreased by combination antiretroviral therapy (cART) in patients infected with human immunodeficiency virus (HIV), but residual activation remains and has been proposed as a cause of premature aging and death, but data are lacking. We analyzed the relationship between T-cell subsets after 18 months of cART and overall survival during 12 years of follow up.
OriginalsprogEngelsk
TidsskriftP L o S One
Vol/bind7
Udgave nummer7
Sider (fra-til)e39356
ISSN1932-6203
DOI
StatusUdgivet - 2012

Citationsformater